Ex vivo-expanded NK cells from blood and ascites of ovarian cancer patients are cytotoxic against autologous primary ovarian cancer cells
出版年份 2018 全文链接
标题
Ex vivo-expanded NK cells from blood and ascites of ovarian cancer patients are cytotoxic against autologous primary ovarian cancer cells
作者
关键词
Ovarian cancer, Natural killer cell cancer immunotherapy, Ex vivo NK cell expansion, Ascites, Autologous natural killer cells
出版物
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 67, Issue 4, Pages 575-587
出版商
Springer Nature
发表日期
2018-01-03
DOI
10.1007/s00262-017-2112-x
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization
- (2017) Silvia Pesce et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The Unique Molecular and Cellular Microenvironment of Ovarian Cancer
- (2017) Thomas Worzfeld et al. Frontiers in Oncology
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Generation of Highly Cytotoxic Natural Killer Cells for Treatment of Acute Myelogenous Leukemia Using a Feeder-Free, Particle-Based Approach
- (2015) Jeremiah L. Oyer et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Induced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer
- (2015) David L. Hermanson et al. STEM CELLS
- Comparative study of various subpopulations of cytotoxic cells in blood and ascites from patients with ovarian carcinoma
- (2015) Sarka Lukesova et al. Wspolczesna Onkologia-Contemporary Oncology
- The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer
- (2015) Katayoun Rezvani et al. Frontiers in Immunology
- B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape
- (2015) Silvia Pesce et al. OncoImmunology
- A Think Tank of TINK/TANKs: Tumor-Infiltrating/Tumor-Associated Natural Killer Cells in Tumor Progression and Angiogenesis
- (2014) Antonino Bruno et al. JNCI-Journal of the National Cancer Institute
- NK cell-based immunotherapy for malignant diseases
- (2013) Min Cheng et al. Cellular & Molecular Immunology
- Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model
- (2013) Melissa A. Geller et al. CYTOTHERAPY
- Antigen Presenting Cell-Mediated Expansion of Human Umbilical Cord Blood Yields Log-Scale Expansion of Natural Killer Cells with Anti-Myeloma Activity
- (2013) Nina Shah et al. PLoS One
- Current Status and Evolution of Preclinical Drug Development Models of Epithelial Ovarian Cancer
- (2013) Panagiotis A. Konstantinopoulos et al. Frontiers in Oncology
- Getting to Know Ovarian Cancer Ascites: Opportunities for Targeted Therapy-Based Translational Research
- (2013) Nuzhat Ahmed et al. Frontiers in Oncology
- Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
- (2012) Cecele J. Denman et al. PLoS One
- A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment
- (2011) H. Kulbe et al. CANCER RESEARCH
- Abagovomab: an anti-idiotypic CA-125 targeted immunotherapeutic agent for ovarian cancer
- (2011) Rachel N Grisham et al. Immunotherapy
- CD56brightCD16+ NK Cells: A Functional Intermediate Stage of NK Cell Differentiation
- (2011) V. Beziat et al. JOURNAL OF IMMUNOLOGY
- Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process
- (2011) Jan Spanholtz et al. PLoS One
- Expansion, Purification, and Functional Assessment of Human Peripheral Blood NK Cells
- (2011) Srinivas S. Somanchi et al. Jove-Journal of Visualized Experiments
- A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
- (2010) Melissa A. Geller et al. CYTOTHERAPY
- MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells
- (2010) Jennifer AA Gubbels et al. Molecular Cancer
- Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells
- (2009) M. Carlsten et al. JOURNAL OF IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started